163 related articles for article (PubMed ID: 27029063)
1. Peripheral lymphocyte subset variation predicts prostate cancer carbon ion radiotherapy outcomes.
Yang ZR; Zhao N; Meng J; Shi ZL; Li BX; Wu XW; Li P; Zhang Q; Wei XB; Fu S
Oncotarget; 2016 May; 7(18):26422-35. PubMed ID: 27029063
[TBL] [Abstract][Full Text] [Related]
2. Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.
Okada T; Tsuji H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Tsujii H;
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):968-72. PubMed ID: 22898380
[TBL] [Abstract][Full Text] [Related]
3. Reference ranges of lymphocyte subsets in healthy adults and adolescents with special mention of T cell maturation subsets in adults of South Florida.
Valiathan R; Deeb K; Diamante M; Ashman M; Sachdeva N; Asthana D
Immunobiology; 2014 Jul; 219(7):487-96. PubMed ID: 24661720
[TBL] [Abstract][Full Text] [Related]
4. A multi-institutional analysis of prospective studies of carbon ion radiotherapy for prostate cancer: A report from the Japan Carbon ion Radiation Oncology Study Group (J-CROS).
Nomiya T; Tsuji H; Kawamura H; Ohno T; Toyama S; Shioyama Y; Nakayama Y; Nemoto K; Tsujii H; Kamada T
Radiother Oncol; 2016 Nov; 121(2):288-293. PubMed ID: 27836119
[TBL] [Abstract][Full Text] [Related]
5. Effects of definitive and salvage radiotherapy on the distribution of lymphocyte subpopulations in prostate cancer patients.
Sage EK; Schmid TE; Geinitz H; Gehrmann M; Sedelmayr M; Duma MN; Combs SE; Multhoff G
Strahlenther Onkol; 2017 Aug; 193(8):648-655. PubMed ID: 28500490
[TBL] [Abstract][Full Text] [Related]
6. Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
Marvaso G; Jereczek-Fossa BA; Vischioni B; Ciardo D; Giandini T; Hasegawa A; Cattani F; Carrara M; Ciocca M; Bedini N; Villa S; Morlino S; Russo S; Zerini D; Colangione SP; Panaino CMV; Fodor C; Santoro L; Pignoli E; Valvo F; Valdagni R; De Cobelli O; Orecchia R
Tumori; 2017 May; 103(3):314-318. PubMed ID: 28009421
[TBL] [Abstract][Full Text] [Related]
7. Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life.
Ishikawa H; Katoh H; Kaminuma T; Kawamura H; Ito K; Matsui H; Hirato J; Shimizu N; Takezawa Y; Tsuji H; Suzuki K; Ohno T; Nakano T;
Anticancer Res; 2015 Oct; 35(10):5559-66. PubMed ID: 26408726
[TBL] [Abstract][Full Text] [Related]
8. Enhanced activated T cell subsets in prostate cancer patients receiving iodine-125 low-dose-rate prostate brachytherapy.
Kubo M; Satoh T; Ishiyama H; Tabata KI; Tsumura H; Komori S; Iwamura M; Baba S; Hayakawa K; Kawamura T; Obata F
Oncol Rep; 2018 Jan; 39(1):417-424. PubMed ID: 29138841
[TBL] [Abstract][Full Text] [Related]
9. [Association of traumatic severity with change in lymphocyte subsets in the early stage after trauma].
Hua R; Chen FX; Zhang YM; Zhou ZH; Wang SJ; Liang J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2013 Aug; 25(8):489-92. PubMed ID: 24021046
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1/2 clinical trial (protocol 9704).
Wakatsuki M; Kato S; Ohno T; Karasawa K; Kiyohara H; Tamaki T; Ando K; Tsujii H; Nakano T; Kamada T; Shozu M;
Cancer; 2014 Jun; 120(11):1663-9. PubMed ID: 24591084
[TBL] [Abstract][Full Text] [Related]
11. [Clinical significance of detecting peripheral blood T lymphocyte subsets in patients with pulmonary adenocarcinoma].
Zhao X; Yan X; Sun S; Wu Z; Jiao S
Nan Fang Yi Ke Da Xue Xue Bao; 2012 May; 32(5):752-4. PubMed ID: 22588942
[TBL] [Abstract][Full Text] [Related]
12. Five-year quality of life assessment after carbon ion radiotherapy for prostate cancer.
Maruyama K; Tsuji H; Nomiya T; Katoh H; Ishikawa H; Kamada T; Wakatsuki M; Akakura K; Shimazaki J; Aoyama H; Tsujii H;
J Radiat Res; 2017 Mar; 58(2):260-266. PubMed ID: 28043947
[TBL] [Abstract][Full Text] [Related]
13. Imbalance in absolute counts of T lymphocyte subsets in patients with head and neck cancer and its relation to disease.
Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL
Adv Otorhinolaryngol; 2005; 62():161-72. PubMed ID: 15608426
[TBL] [Abstract][Full Text] [Related]
14. Immunomodulatory effects of carbon ion radiotherapy in patients with localized prostate cancer.
Hu W; Pei Y; Ning R; Li P; Zhang Z; Hong Z; Bao C; Guo X; Sun Y; Zhang Q
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4533-4545. PubMed ID: 36138265
[TBL] [Abstract][Full Text] [Related]
15. Long-term immune dysfunction after radiotherapy to the head and neck area.
Verastegui EL; Morales RB; Barrera-Franco JL; Poitevin AC; Hadden J
Int Immunopharmacol; 2003 Aug; 3(8):1093-1104. PubMed ID: 12860166
[TBL] [Abstract][Full Text] [Related]
16. A prospective nonrandomized phase I/II study of carbon ion radiotherapy in a favorable subset of locally advanced non-small cell lung cancer (NSCLC).
Takahashi W; Nakajima M; Yamamoto N; Yamashita H; Nakagawa K; Miyamoto T; Tsuji H; Kamada T; Fujisawa T
Cancer; 2015 Apr; 121(8):1321-7. PubMed ID: 25641119
[TBL] [Abstract][Full Text] [Related]
17. Increase in memory (CD4+CD29+ and CD4+CD45RO+) T and naive (CD4+CD45RA+) T-cell subpopulations in smokers.
Tanigawa T; Araki S; Nakata A; Kitamura F; Yasumoto M; Sakurai S; Kiuchi T
Arch Environ Health; 1998; 53(6):378-83. PubMed ID: 9886155
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte subsets in the course of continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Leander M
Adv Perit Dial; 2001; 17():10-4. PubMed ID: 11510253
[TBL] [Abstract][Full Text] [Related]
19. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
[TBL] [Abstract][Full Text] [Related]
20. [Immune reconstitution after allogeneic peripheral blood stem cell transplantation].
Hong M; Li JY; Qian SX; Wu HX; Lu H; Zhang R; Zhang XY; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1130-4. PubMed ID: 18928611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
